Duodenoscopes Market Size to Exceed USD 338.1 Mn by 2032

The Duodenoscopes Market, estimated at USD 213.3 Mn in 2025, is expected to exhibit a CAGR of 6.8% and reach USD 338.1 Mn by 2032.

The industry is witnessing significant growth driven by rising demand for advanced, reliable, and cost-effective medical devices across diagnostic, therapeutic, and monitoring applications. Rapid advancements in device design, digital health integration, and adoption of minimally invasive technologies are reshaping the competitive landscape. Furthermore, supportive regulatory frameworks, increasing healthcare investments, and the growing focus on patient-centric care are expected to create new growth avenues for market players.

Key market players are focused on adopting growth strategies such as partnerships, and this is expected to drive the global duodenoscopes market growth. For instance, in March 2025, Skytron, a healthcare safety & efficiency company that specializes in capital equipment, and  arthrex inc, is a manufacturing invasive surgical technology, announced the partnership to offer a comprehensive array of duodenoscopes solutions designed to address the future needs and challenges of operative care facilities.

Global Duodenoscopes Market– Impact of Coronavirus (COVID-19) Pandemic

The World Health Organization (WHO) designated the illness caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which first appeared in Wuhan (province of Hubei, China), in the last months of 2025, as "coronavirus disease 2025" or COVID-19. This virus spreads quickly, and had a serious negative impact on the economies, social behaviors, and healthcare of every country in the world.

COVID-19 affected the economy in three main ways: by directly affecting production and demand, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to the lockdown, several countries such as India, China, Brazil, and others faced problems regarding transportation of thingss from one place to another.

COVID-19 had positive impact on the global duodenoscopes market..For instance, in April 2025, Siemens Healthcare GmbH is a medical device company in Germany, launched RAPIDPoint 500e Blood duoendoscopes analyzer, adding to the company's product lineup and supporting COVID-19 initiatives.

Global Duodenoscopes Market: Key Developments

In May 2025, F. Hoffmann-La Roche Ltd., a multinational healthcare company, announced the acquisition of Stratos Genomics is Biotechnology company in Seattle, Washington., development of Duodenoscopes device was made by this acquisition. This enhanced the business's healthcare diagnosing division and raised its revenue-generating capacity.

In February 2025, Fujifilm India Pvt Ltd, a medical imaging and diagnostic technologies company, announced its life sciences strategic investment fund managed by the Life Sciences Corporate Venture Capital (LS-CVC), a newly established group within the Fujifilm’s Life Sciences Strategy Headquarters in Tokyo, Japan. Fujifilm is initially investing US$ 60 million  to start the fund, targeting cutting-edge biotechnology primarily through partnerships with early-stage companies around the world.

In August 2025, Hoya Corporation, a endoscope technology innovation company, announced that it had entered into a strategic joint venture (JV) with Jiangsu Sigo, a China-based plastic manufacturer. The partnership provides HOoya Corporation with access to a wider range of high-quality plastic and polycarbonate finished, enhancing the company’s existing endoscopic portfolio, and providing a more sustainable supply chain for customers.

In May 2025, Leica Microsystems, a Germany-based microscope manufacturing company, launched Stellaris, its new flagship confocal microscopy platform that is designed to significantly improve how scientists are able to capture three-dimensional images of living cells and tissues. This platform enables three-dimensional viewing of live tissues and cells.

Browse 36 Market Data Tables and 26 Figures spread through 180 Pages and in-depth TOC on “Global Duodenoscopes Market”- Forecast to 2032, Global Duodenoscopes Market, by Product Type (Flexible Duodenoscopes and Rigid Duodenoscopes), by Application (Diagnostics and Therapeutics), by End User (Hospitals, Clinics, and Ambulatory Centers),  and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

To know the latest trends and insights prevalent in this market, click the link below:

https://www.coherentmarketinsights.com/market-insight/duodenoscopes-market-3779

Key Takeaways of the Global Duodenoscopes Market :

• The global duodenoscopes market is expected to exhibit a CAGR of 6.8%  during the forecast period. The merger with emerging economies offers lucrative growth opportunities for players in the global duodenoscopes market.
• Among End User, Hospitals is expected to hold a dominant position in the global duodenoscopes market during the forecast period, owing to hospitals are Partnership with diagnostic labrotary in the field of duodenoscopes. For instance, in November 2025, Neuberg Diagnostics Private Limited, a diagnostic labrotary in India, expanded its presence in India with inauguration of new lab in Kerala partnership with kochi government hospital. It had also set up a CLIA approved molecular and genomic lab in the USA.
• Among region, North America is expected to be the dominant region in the global duodenoscopes market, owing to the key players are focusing on inorganic strategies such as definitive agreements. For instance, In July 2025, Beckman Coulter, a clinical diagnostics company, announced that it has entered into definitive agreements with Quidel Corporation is a manufacturer of diagnostic healthcare products in U.S., to obtain all rights related to the manufacture, distribution, and sale of a BNP assay for Beckman Coulter analyzers. Under the terms of the agreements, Quidel will continue to manufacture and supply certain components to Beckman Coulter related to the assay, and Beckman Coulter will exclusively manufacture and sell to customers the BNP assay currently sold as TRIAGE BNP by Quidel, under the brand name Access BNP.

Major players operating in the global duodenoscopes market Custom Ultrasonics, Inc., ENDOMED, Fujifilm Holdings Corporation, Hoya Corporation, KARL STORZ GmbH & Co. KG., Olympus Corporation, PENTAX Medical Company, Ambu A/S, Boston Scientific Corporation, EndoMed Systems, HOYA Corp., CONMED Corporation, Becton, Dickinson and Company, B. Braun Melsungen AG, Cook Group and SonoScape Medical Corp.